Redwood AI Plots Quantum Future with All-Stock Takeover and Federal Grant

Redwood AI moves beyond drug discovery, acquiring Quantum.IQ for quantum-resilient encryption; deal includes up to 14 million shares and government research funding.

Redwood AI is carving out a new identity. The Vancouver-based company, best known for applying artificial intelligence to chemistry and drug discovery, has set its sights on the emerging market for post-quantum cryptography. A non-binding letter of intent to buy Quantum.IQ, a specialist in quantum-resilient security software, marks the most ambitious leg of that push.

Quantum.IQ’s platform helps governments, defence departments, financial firms and critical infrastructure operators identify weaknesses in their encryption systems and migrate to standards that can withstand quantum computer attacks. Redwood sees the technology as a natural fit with its own AI infrastructure — cryptographic intelligence and security planning for highly sensitive environments, at least theoretically.

The deal is structured entirely in shares. Redwood would issue up to 7 million common shares at closing, with a further 7 million contingent on hitting specific milestones, for a maximum of 14 million shares in total. Completion hinges on a definitive agreement, a clean due-diligence process and approval from the Canadian Securities Exchange. Quantum.IQ would become a direct or indirect subsidiary. Its chief executive, Kevin O'Neill, brings more than 35 years of experience building technology ventures and has previously co-founded companies that sold to Microsoft, Packeteer and Patriot One.

The quantum push comes against a backdrop of other strategic moves. A wholly owned subsidiary of Redwood AI received a funding commitment of up to CAD 240,000 from the National Research Council of Canada's Industrial Research Assistance Program for the Q-SAFE research project, which focuses on quantum-optimised classification of hazardous chemicals.

Redwood has also been working to improve access for US investors. Its shares are now eligible for electronic settlement through the Depository Trust Company (DTC), a step designed to boost liquidity. Separately, the company hired InvestorBrandNetwork for digital media and communications through 30 September 2026, at a cash fee of USD 114,000, with no stock component.

The past month has been unusually active. Earlier in May, Redwood entered a collaboration with Resilience Biosciences, a Vancouver-based clinical biopharma firm developing non-opioid therapies for withdrawal symptoms. Redwood is providing AI-powered workflows for molecular development. The company was also named one of Innovate BC's "Top 25 Investible Companies" from British Columbia, presenting to international investors.

Whether the acquisition of Quantum.IQ moves from a letter of intent to a binding contract will be decided in the weeks ahead as due diligence runs its course. For now, Redwood is betting that the intersection of artificial intelligence, quantum security and government research funding can produce a coherent story — even if the pieces remain far apart.